One in 20 Australian women now receiving iron IVs
The number of Australian women receiving intravenous iron treatments has surged dramatically over the past decade, with new research revealing that one in 20 women of reproductive age… read more.
The number of Australian women receiving intravenous iron treatments has surged dramatically over the past decade, with new research revealing that one in 20 women of reproductive age… read more.
Emergency Medicine & Intensive Care
Airline emergency medical kits should include benzodiazepines so that cabin crew and responding clinicians can treat passengers who have a seizure mid-flight, according to a Viewpoint published in… read more.
Takeda announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with… read more.
Chronic kidney disease (CKD) is currently ranked the ninth leading cause of death globally[1]. However, up to half of the cases may remain undetected despite the availability of… read more.
Personal care products are among the largest everyday sources of exposure to endocrine-disrupting chemicals, and high schoolers who follow social media influencers or watch beauty tutorials seem to… read more.
Regeneron Pharmaceuticals, Inc. announced the FDA has granted approval for Pasatru (garetosmab-grts) to reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans… read more.
For sleep-deprived nursing moms, artificial intelligence may feel like a lifeline. In fact, a new national survey from Orlando Health reveals if women ages 18 to 44 had an urgent… read more.
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU’s Pennington… read more.
NICE(UK): Acalabrutinib plus venetoclax can be used as an option for untreated chronic lymphocytic leukaemia (CLL) in adults. It can only be used: i) without obinutuzumab, and ii)… read more.
An analysis of 103 European cities’ 2030 climate neutral plans (including 22 capital cities) shows that municipalities are planning to rely on carbon removal to compensate for about… read more.
A real-time prescription benefit (RTPB) tool did not change overall prescription fill rates but did increase fill rates for high-cost medications, according to a post hoc analysis of… read more.
Knight Therapeutics Inc. announced the launch of Wynzora, a uniform white aqueous cream containing 0.05 mg/g of calcipotriol (CAL) and 0.5 mg/g of betamethasone dipropionate (BDP), in Canada…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.